Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2015 (2015), Article ID 327980, 3 pages
http://dx.doi.org/10.1155/2015/327980
Case Report

Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic Syndrome

1Department of Internal Medicine, The Ohio State University, 395 W. 12th Avenue, Third Floor, Columbus, OH 43210, USA
2Division of Hematology, The Ohio State University, 320 W. 10th Avenue, Columbus, OH 43210, USA

Received 3 September 2015; Accepted 11 October 2015

Academic Editor: Gergely Feher

Copyright © 2015 John L. Vaughn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Noris and G. Remuzzi, “Hemolytic uremic syndrome,” Journal of the American Society of Nephrology, vol. 16, no. 4, pp. 1035–1050, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. R. Cataland and H. M. Wu, “Diagnosis and management of complement mediated thrombotic microangiopathies,” Blood Reviews, vol. 28, no. 2, pp. 67–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. R. Cataland and H. M. Wu, “How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome,” Blood, vol. 123, no. 16, pp. 2478–2484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. Gami, S. R. Hayman, J. P. Grande, and V. D. Garovic, “Incidence and prognosis of acute heart failure in the thrombotic microangiopathies,” The American Journal of Medicine, vol. 118, no. 5, pp. 544–547, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. N. J. Thomas, J. J. Messina, W. J. Debruin, and J. A. Carcillo, “Cardiac failure in hemolytic uremic syndrome and rescue with extracorporeal life support,” Pediatric Cardiology, vol. 26, no. 1, pp. 104–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Noris and G. Remuzzi, “Cardiovascular complications in atypical haemolytic uraemic syndrome,” Nature Reviews. Nephrology, vol. 10, no. 3, pp. 174–180, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. J. Akashi, D. S. Goldstein, G. Barbara, and T. Ueyama, “Takotsubo cardiomyopathy: a new form of acute, reversible heart failure,” Circulation, vol. 118, no. 25, pp. 2754–2762, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Bienaime, M.-A. Dragon-Durey, C. H. Regnier et al., “Mutations in components of complement influence the outcome of factor I-associated atypical hemolytic uremic syndrome,” Kidney International, vol. 77, no. 4, pp. 339–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. E. Saunders, C. Abarrategui-Garrido, V. Frémeaux-Bacchi et al., “The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models,” Human Mutation, vol. 28, no. 3, pp. 222–234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Kavanagh, T. H. Goodship, and A. Richards, “Atypical hemolytic uremic syndrome,” Seminars in Nephrology, vol. 33, no. 6, pp. 508–530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Loirat and V. Frémeaux-Bacchi, “Atypical hemolytic uremic syndrome,” Orphanet Journal of Rare Diseases, vol. 6, article 60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Legendre, C. Licht, P. Muus et al., “Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome,” The New England Journal of Medicine, vol. 368, no. 23, pp. 2169–2181, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Ardissino, S. Testa, I. Possenti et al., “Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases,” American Journal of Kidney Diseases, vol. 64, no. 4, pp. 633–637, 2014. View at Publisher · View at Google Scholar · View at Scopus